全文获取类型
收费全文 | 1826篇 |
免费 | 76篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 136篇 |
妇产科学 | 17篇 |
基础医学 | 140篇 |
口腔科学 | 73篇 |
临床医学 | 178篇 |
内科学 | 325篇 |
皮肤病学 | 52篇 |
神经病学 | 322篇 |
特种医学 | 287篇 |
外科学 | 144篇 |
综合类 | 30篇 |
预防医学 | 52篇 |
眼科学 | 23篇 |
药学 | 93篇 |
中国医学 | 3篇 |
肿瘤学 | 99篇 |
出版年
2023年 | 15篇 |
2022年 | 16篇 |
2021年 | 20篇 |
2020年 | 19篇 |
2019年 | 25篇 |
2018年 | 34篇 |
2017年 | 14篇 |
2016年 | 29篇 |
2015年 | 31篇 |
2014年 | 38篇 |
2013年 | 47篇 |
2012年 | 53篇 |
2011年 | 69篇 |
2010年 | 61篇 |
2009年 | 79篇 |
2008年 | 51篇 |
2007年 | 84篇 |
2006年 | 55篇 |
2005年 | 68篇 |
2004年 | 57篇 |
2003年 | 51篇 |
2002年 | 54篇 |
2001年 | 55篇 |
2000年 | 56篇 |
1999年 | 31篇 |
1998年 | 98篇 |
1997年 | 80篇 |
1996年 | 67篇 |
1995年 | 71篇 |
1994年 | 50篇 |
1993年 | 47篇 |
1992年 | 38篇 |
1991年 | 29篇 |
1990年 | 46篇 |
1989年 | 53篇 |
1988年 | 42篇 |
1987年 | 30篇 |
1986年 | 26篇 |
1985年 | 34篇 |
1984年 | 22篇 |
1983年 | 15篇 |
1982年 | 18篇 |
1981年 | 10篇 |
1980年 | 15篇 |
1979年 | 9篇 |
1978年 | 13篇 |
1977年 | 17篇 |
1976年 | 13篇 |
1975年 | 13篇 |
1900年 | 2篇 |
排序方式: 共有1977条查询结果,搜索用时 31 毫秒
1.
P Avalos-Peralta† A Herrera† JJ Ríos-Martín‡ AM Pérez-Bernal† D Moreno-Ramírez† F Camacho† 《Journal of the European Academy of Dermatology and Venereology》2006,20(1):79-83
We report the case of a patient with a 13-year history of pemphigus vulgaris (PV) treated with immunosuppressive agents, prednisone and mycophenolate mofetil who had developed lesions of Kaposi's sarcoma (KS) on a sole plaque of PV that had been previously treated with intralesional injections of steroids. The lesions were surgically removed and polymerase chain reaction (PCR) demonstrated human herpesvirus-8 (HHV-8) DNA. There were neither recurrences nor later dissemination of KS following gradual decrease of the immunosuppressive therapy. We suggest that the treatment with intralesional steroids may have influenced the local reactivation of a latent infection of the virus, determining the appearance of this localized KS. 相似文献
2.
3.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
4.
5.
6.
Dedifferentiated chondrosarcoma 总被引:2,自引:0,他引:2
M. Mercuri M.D. P. Picci M.D. L. Campanacci M.D. E. Rulli M.D. 《Skeletal radiology》1995,24(6):409-416
We reviewed 74 cases of dedifferentiated central and peripheral chondrosarcoma. Histologically these tumours consist of an underlying cartilaginous component (either benign or malignant) juxtaposed to a highgrade non-cartilaginous component, with a typically abrupt transition between the two tissue types. The noncartilaginous component may constitute a very small or a very large proportion of the tumour, so diagnosis often requires histological evaluation of the entire tumour. The diagnosis is often suspected on the basis of the clinical course and careful evaluation of the radiographie characteristics. Central dedifferentiated chondrosarcoma can be classified radiographically into three types. In type 1 (36 cases in our review) the radiographie features are the same as those of a central chondrosarcoma, with the addition of a region with very aggressive radiographie features. Type 2 lesions (20 cases) resemble the underlying benign enchondroma but also have destructive changes and/or a large soft tissue mass. Type 3 lesions (8 cases) are not distinctive radiographically and present as a very high grade destructive lesion of bone. These cases are diagnosed following biopsy or tumour resection. The prognosis of these tumours is extremely poor, with 13% overall 5-year survival in this series. Improved survival was found in those cases where diagnosis was prompt and surgical treatment with a wide or radical margin was attained. No benefit was found from the use of adjuvant chemotherapy or radiotherapy. Thus, early recognition of the characteristic radiographie features, adequate histological sampling, and wide or radical surgical margins are necessary for satisfactory management of this highly malignant variant of chondrosarcoma. 相似文献
7.
8.
SUMMARY A young patient presenting with splenomegaly and hypersplenism was inadvertently found to have selective IgA deficiency. There were no symptoms of immunodeficiency and the patient responded well to splenectomy, with return of blood counts to normal without adverse effects. No other cause for the hypersplenism was found. We postulate selective IgA deficiency as a cause of splenomegaly and hypersplenism. 相似文献
9.
Felipe Scalco Manzano DDSc Lucia Mercuri Granero MD Danilo Masiero MD Maria Teresa Botti Rodrigues dos Santos DDSc PhD 《Special care in dentistry》2004,24(4):235-239
This study was designed to verify the safety and efficacy of botulinum toxin type A (BTX-A) used as a neuromuscular block on spastic masticatory musculature of children with cerebral palsy. Six patients who had spastic-tetraplegic cerebral-palsy, aged 5 to 20 years were selected. All patients had spasticity of the jaw muscles, bruxism, lower lip trauma, limited mouth opening, and difficulties in cleaning the oral cavity. The patients were sedated under general anesthesia, while the dentist injected the masseter and temporalis muscles bilaterally with 150 and 75 units of BTX-A each. Clinical examinations were conducted at 7, 14, 30, and 90 days after the initial appointment. We found statistically significant decreases in muscle spasticity and bruxism ( p = 0.002), improved inter-incisal opening ( p = 0.002), improved oral hygiene ( p = 0.031), and less lower lip trauma ( p = 0.060) after the neuromuscular blocking. 相似文献
10.